T

Tabula Rasa HealthCare Inc
F:43T

Watchlist Manager
Tabula Rasa HealthCare Inc
F:43T
Watchlist
Price: 9.6 EUR Market Closed
Market Cap: 260.4m EUR

Relative Value

There is not enough data to reliably calculate the relative value of 43T.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

43T Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0.8
Median 5Y
0.8
Industry
2.3
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-3
Industry
22.4
vs History
vs Industry
Median 3Y
-54.7
Median 5Y
2.8
Industry
14.4
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.3
Industry
21.7
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-3.5
Industry
2.2
vs History
vs Industry
Median 3Y
1.6
Median 5Y
1.6
Industry
2.5
vs History
vs Industry
Median 3Y
6.8
Median 5Y
6.8
Industry
5.1
vs History
vs Industry
Median 3Y
-20.1
Median 5Y
-20.1
Industry
12
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-10.6
Industry
16.9
vs History
vs Industry
Median 3Y
-105
Median 5Y
15.4
Industry
14.5
vs History
vs Industry
Median 3Y
-22.5
Median 5Y
-23.1
Industry
18.6
vs History
vs Industry
Median 3Y
2
Median 5Y
2
Industry
1.8

Multiples Across Competitors

43T Competitors Multiples
Tabula Rasa HealthCare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Tabula Rasa HealthCare Inc
F:43T
259.8m EUR 0.9 -3.2 -21 -11
US
Veeva Systems Inc
NYSE:VEEV
36.6B USD 11.9 42.5 32.2 33.6
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
24.3B AUD 110 210.5 145.5 145.5
JP
M3 Inc
TSE:2413
1.4T JPY 4.3 30.7 15.6 19.2
US
Doximity Inc
NYSE:DOCS
8.3B USD 13.3 32.7 28.9 30.2
US
Waystar Holding Corp
NASDAQ:WAY
5.7B USD 5.5 51 17.2 26.9
SE
Sectra AB
STO:SECT B
48.7B SEK 21.8 75.4 -149.1 -149.1
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
300.1B INR 11.3 61.7 38.4 44.8
US
Inspire Medical Systems Inc
NYSE:INSP
2.8B USD 3.1 61.7 50.5 67.9
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.4B CNY 9 -63 -124.6 -124.6
P/E Multiple
Earnings Growth PEG
US
T
Tabula Rasa HealthCare Inc
F:43T
Average P/E: 68.8
Negative Multiple: -3.2
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
42.5
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
210.5
32%
6.6
JP
M3 Inc
TSE:2413
30.7
16%
1.9
US
Doximity Inc
NYSE:DOCS
32.7
18%
1.8
US
W
Waystar Holding Corp
NASDAQ:WAY
51
N/A N/A
SE
Sectra AB
STO:SECT B
75.4
28%
2.7
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
61.7
30%
2.1
US
Inspire Medical Systems Inc
NYSE:INSP
61.7
13%
4.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -63
92%
N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
T
Tabula Rasa HealthCare Inc
F:43T
Average EV/EBITDA: 43.8
Negative Multiple: -21
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
32.2
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
145.5
32%
4.5
JP
M3 Inc
TSE:2413
15.6
14%
1.1
US
Doximity Inc
NYSE:DOCS
28.9
23%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
17.2
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -149.1 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
38.4
24%
1.6
US
Inspire Medical Systems Inc
NYSE:INSP
50.5
80%
0.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -124.6
36%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
T
Tabula Rasa HealthCare Inc
F:43T
Average EV/EBIT: 51.4
Negative Multiple: -11
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.6
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
145.5
31%
4.7
JP
M3 Inc
TSE:2413
19.2
N/A N/A
US
Doximity Inc
NYSE:DOCS
30.2
25%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
26.9
56%
0.5
SE
Sectra AB
STO:SECT B
Negative Multiple: -149.1 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
44.8
27%
1.7
US
Inspire Medical Systems Inc
NYSE:INSP
67.9
34%
2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -124.6
47%
N/A